Compare TRC & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRC | FENC |
|---|---|---|
| Founded | 1843 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.4M | 366.8M |
| IPO Year | 1995 | 2010 |
| Metric | TRC | FENC |
|---|---|---|
| Price | $17.11 | $13.33 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $17.40 |
| AVG Volume (30 Days) | 123.5K | ★ 215.3K |
| Earning Date | 11-05-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.22 | 0.19 |
| Revenue | $37,830,000.00 | ★ $44,642,000.00 |
| Revenue This Year | $10.83 | $67.26 |
| Revenue Next Year | N/A | $42.94 |
| P/E Ratio | $77.73 | ★ $71.37 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.31 | $5.65 |
| 52 Week High | $21.31 | $13.64 |
| Indicator | TRC | FENC |
|---|---|---|
| Relative Strength Index (RSI) | 52.72 | 72.74 |
| Support Level | $15.87 | $9.58 |
| Resistance Level | $19.78 | N/A |
| Average True Range (ATR) | 0.53 | 0.89 |
| MACD | 0.02 | 0.33 |
| Stochastic Oscillator | 47.50 | 98.20 |
Tejon Ranch Co is a diversified real estate development and agribusiness company. It has six reporting segments: Real Estate - Commercial/Industrial, Multifamily, Real Estate - Resort/Residential, Mineral Resources, Farming, and Ranch Operations.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.